receptor, muscarinic m1

Preferred Label : receptor, muscarinic m1;

MeSH definition : A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.;

MeSH synonym : muscarinic receptor m1; m1, muscarinic receptors; m1 receptor, muscarinic; m1 receptors, muscarinic; muscarinic m1 receptor; muscarinic receptors m1; receptors m1, muscarinic; receptors, muscarinic m1; muscarinic m1 receptors; m1, muscarinic receptor; receptor m1, muscarinic;

Is substance : O;

Détails

Origin ID

D043643;

UMLS CUI

C0531859;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- physiology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
Indexing information
- 1-((4-cyano-4-(pyridine-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid [MeSH Supplementary Concept]
- 1-((4-cyano-4-pyridin-2-ylpiperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid [MeSH Supplementary Concept]
- 1-(1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo(d)imidazol-2-(3H)-one [MeSH Supplementary Concept]
- 4-(3-(4-butylpiperidin-1-yl)propyl)-7-fluoro-4H-benzo(1,4)oxazin-3-one [MeSH Supplementary Concept]
- 5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine [MeSH Supplementary Concept]
- GSK 1034702 [MeSH Supplementary Concept]
- N-(1-(3-(3-oxo-2,3-dihydrobenzo(1,4)oxazin-4-yl)propyl)piperidin-4-yl)-2-phenylacetamide [MeSH Supplementary Concept]
- N-(3-oxo-3-(4-(pyridin-4-yl)piperazin-1-yl)propyl)benzo(c)(1,2,5)thiadiazole-4-sulfonamide [MeSH Supplementary Concept]
- N-(6-((1-((4-fluorobenzyl)(methyl)amino)ethylidene))amino)-2-hydroxy-2,3-dihydro-1H-inden-1-ylbiphenyl-4-carboxamide [MeSH Supplementary Concept]
- VU 0405652 [MeSH Supplementary Concept]
- VU0357017 [MeSH Supplementary Concept]
- VU0364572 [MeSH Supplementary Concept]
- VU0415248 [MeSH Supplementary Concept]
- VU0431263 [MeSH Supplementary Concept]
- VU0433670 [MeSH Supplementary Concept]
- VU0455691 [MeSH Supplementary Concept]
- fluoroxanomeline [MeSH Supplementary Concept]
Record concept(s)
- receptor, muscarinic M1 [MeSH concept]
Related MeSH Supplementary Concept(s)
- CHRM1 protein, human [MeSH Supplementary Concept]
- Chrm1 protein, mouse [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients